Norway childhood vaccine schedule: 9 vaccines by age
For babies (first year): Hepatitis B, DTaP / Tdap, Polio (IPV), Hib, Pneumococcal (PCV), Rotavirus, MMR. Click a vaccine for its Norway-specific page and its schedule in every other country.
| Vaccine | Status | Doses & recommended age |
|---|---|---|
| Hepatitis B · side effects & data | Universal | Dose 1 — 3 months (Hexavalent (DTaP/IPV/Hib/HepB)) Dose 2 — 5 months (Hexavalent (DTaP/IPV/Hib/HepB)) Dose 3 — 12 months (Hexavalent (DTaP/IPV/Hib/HepB)) |
| DTaP / Tdap · side effects & data | Universal | Dose 1 — 3 months Dose 2 — 5 months Dose 3 — 12 months Booster — 6 years Booster — 15 years |
| Polio (IPV) · side effects & data | Universal | Dose 1 — 3 months (IPV) Dose 2 — 5 months (IPV) Dose 3 — 12 months (IPV) Booster — 6 years (IPV) Booster — 15 years (IPV) |
| Hib · side effects & data | Universal | Dose 1 — 3 months Dose 2 — 5 months Dose 3 — 12 months |
| Pneumococcal (PCV) · side effects & data | Universal | Dose 1 — 3 months Dose 2 — 5 months Dose 3 — 12 months |
| Rotavirus · side effects & data | Universal | Dose 1 — 6 weeks (Rotavirus (oral)) Dose 2 — 3 months (Rotavirus (oral)) |
| MMR · side effects & data | Universal | Dose 1 — 15 months (MMR) Dose 2 — 6 years (MMR) |
| HPV · side effects & data | Universal | Dose 1 — 12 years Dose 2 — 6-12 months after dose 1 |
| Influenza (flu) · side effects & data | Selective / risk-based | Annual — Risk groups and 65+ |
Norway vaccine schedule vs. the United States
Norway and the United States share 9 routine vaccines. The U.S. routinely gives Varicella (chickenpox), Hepatitis A, Meningococcal, COVID-19, which Norway does not.
| Vaccine | Norway first dose | U.S. first dose | Doses |
|---|---|---|---|
| Hepatitis B | 3 months | Birth | 3 vs 3 doses |
| DTaP / Tdap | 3 months | 2 months | 5 vs 5 doses |
| Polio (IPV) | 3 months | 2 months | 5 vs 4 doses |
| Hib | 3 months | 2 months | 3 vs 4 doses |
| Pneumococcal (PCV) | 3 months | 2 months | 3 vs 4 doses |
| Rotavirus | 6 weeks | 2 months | 2 vs 3 doses |
| MMR | 15 months | 12-15 months | 2 vs 2 doses |
| HPV | 12 years | 11-12 years | 2 vs 2 doses |
| Influenza (flu) | Risk groups and 65+ | 6 months and older, every season | 1 vs 1 doses |
In the routine U.S. schedule but not Norway's: Varicella (chickenpox), Hepatitis A, Meningococcal, COVID-19.
Why Norway's schedule looks the way it does
Schedules differ mostly because disease burden and health-system conditions differ. WHO/UNICEF estimates of how many children actually receive each vaccine, and the diseases' reported incidence, explain most of the choices below.
- Tuberculosis: 3.3 new cases per 100,000 people per year (2024). BCG is given only to risk groups (e.g. children with TB exposure or from high-incidence families). BCG mainly protects young children from severe TB (meningitis, miliary TB), so countries with high TB incidence give it at birth and low-incidence countries reserve it for risk groups.
- Measles: 0.7 reported cases per million people (2025). Two-dose coverage is 95%; sustained elimination needs roughly 95% coverage with both doses, which is why schedules add or move the second dose when coverage or outbreaks change.
- Hepatitis B birth dose: not part of the WHO-reported universal schedule here. A birth dose matters most where mothers commonly carry hepatitis B, because infection at birth becomes chronic in most infants; countries with low carriage and universal prenatal screening often start hepatitis B vaccination later or target only exposed newborns.
Coverage: share of children who received each vaccine (WHO/UNICEF estimates)
| Vaccine | Norway | United States |
|---|---|---|
| BCG (TB) | not reported | not reported |
| DTP dose 1 | 99% (2025) | 98% (2025) |
| DTP dose 3 | 96% (2025) | 94% (2025) |
| Measles dose 1 | 96% (2025) | 92% (2025) |
| Measles dose 2 | 95% (2025) | 95% (2025) |
| Polio (IPV series) | 96% (2025) | 93% (2025) |
| Hep B birth dose | not reported | 75% (2025) |
| Hep B dose 3 | 96% (2025) | 93% (2025) |
| Hib dose 3 | 97% (2025) | 92% (2025) |
| Pneumococcal (PCV) | 95% (2025) | 84% (2025) |
| Rotavirus (complete) | 95% (2025) | 77% (2025) |
| HPV dose 1, girls | 91% (2025) | 73% (2025) |
Source: WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) and WHO reported incidence, via the WHO Immunization Data portal; TB incidence from the WHO Global Health Observatory (indicator MDG_0000000020). Retrieved 2026-10-09. "Not reported" usually means the vaccine is not in the universal schedule. Polio is the completed inactivated-polio series (IPVC).
Other Europe countries
Denmark · Finland · France · Germany · Italy · Poland · Spain · Sweden · United Kingdom · all 31 countries